Combination therapy with daptomycin, linezolid, and rifampin as treatment option for MRSA meningitis and bacteremia

Diagnostic Microbiology and Infectious Disease

Volumn 71, Issue 3, 2011, Pages 286-290

  Kelesidis, Theodoros ^a   Humphries, Romney ^a   Ward, Kevin ^a   Lewinski, Michael A ^a   Yang, Otto O ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Daptomycin; Linezolid; Meningitis; Methicillin resistant Staphylococcus aureus (MRSA); Rifampin

Indexed keywords

COTRIMOXAZOLE; DALFOPRISTIN PLUS QUINUPRISTIN; DAPTOMYCIN; DOXYCYCLINE; ERYTHROMYCIN; GENTAMICIN; LINEZOLID; RIFAMPICIN; TIGECYCLINE; VANCOMYCIN;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL MENINGITIS; CASE REPORT; CEREBROSPINAL FLUID ANALYSIS; COMBINATION CHEMOTHERAPY; DEVICE INFECTION; DEVICE REMOVAL; DISEASE COURSE; DRUG HYPERSENSITIVITY; HUMAN; LUMBAR PUNCTURE; MALE; MEDICAL HISTORY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS MENINGITIS; MORTALITY; OSTEOMYELITIS; PRIORITY JOURNAL; SHUNT INFECTION; SURGICAL INFECTION;

ACETAMIDES; ANTI-BACTERIAL AGENTS; BACTEREMIA; DAPTOMYCIN; DRUG THERAPY, COMBINATION; HUMANS; MALE; MENINGITIS, BACTERIAL; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; OXAZOLIDINONES; RIFAMPIN; STAPHYLOCOCCAL INFECTIONS; TREATMENT OUTCOME;

EID: 80053905897     PISSN: 07328893     EISSN: 18790070     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2011.07.001     Document Type: Article

References (18)

1. Aguilar J., Urday-Cornejo V., Donabedian S., Perri M., Tibbetts R., Zervos M. Staphylococcus aureus meningitis: case series and literature review. Medicine (Baltimore) 2010, 89:117-125.
2. Baldoni D., Haschke M., Rajacic Z., Zimmerli W., Trampuz A. Linezolid alone or combined with rifampin against methicillin-resistant Staphylococcus aureus in experimental foreign-body infection. Antimicrob. Agents Chemother. 2009, 53:1142-1148.
3. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard 2009, Clinical and Laboratory Standards Institute (CLSI), CLSI, Wayne, PA, M07-A8. eighth edition.
4. Dandache P., Moise P.A., Orsini J., Montecalvo M., Sakoulas G. Reduced biofilm production associated with increasing linezolid MICs among linezolid-resistant staphylococci. J. Antimicrob. Chemother. 2009, 64:1114-1115.
5. Egermann U., Stanga Z., Ramin A., Acosta F., Stucki A., Gerber P., Cottagnoud M., Cottagnoud P. Combination of daptomycin plus ceftriaxone is more active than vancomycin plus ceftriaxone in experimental meningitis after addition of dexamethasone. Antimicrob. Agents Chemother. 2009, 53:3030-3033.
6. Entenza J.M., Giddey M., Vouillamoz J., Moreillon P. In vitro prevention of the emergence of daptomycin resistance in Staphylococcus aureus and enterococci following combination with amoxicillin/clavulanic acid or ampicillin. Int. J. Antimicrob. Agents 2010, 35:451-456.
7. Forrest G.N., Tamura K. Rifampin combination therapy for nonmycobacterial infections. Clin. Microbiol. Rev. 2010, 23:14-34.
8. Gerber P., Stucki A., Acosta F., Cottagnoud M., Cottagnoud P. Daptomycin is more efficacious than vancomycin against a methicillin-susceptible Staphylococcus aureus in experimental meningitis. J. Antimicrob. Chemother. 2006, 57:720-723.
9. Isenberg H.D. Clinical microbiology procedures handbook 1992, American Society for Microbiology, Washington, DC.
10. Jang H.C., Kim S.H., Kim K.H., Other authors Salvage treatment for persistent methicillin-resistant Staphylococcus aureus bacteremia: efficacy of linezolid with or without carbapenem. Clin. Infect. Dis. 2009, 49:395-401.
11. Jaspan H.B., Brothers A.W., Campbell A.J., McGuire J.K., Browd S.R., Manley T.J., Pak D., Weissman S.J. Multidrug-resistant Enterococcus faecium meningitis in a toddler: characterization of the organism and successful treatment with intraventricular daptomycin and intravenous tigecycline. Pediatr. Infect. Dis. J. 2010, 29:379-381.
12. Kessler A.T., Kourtis A.P. Treatment of meningitis caused by methicillin-resistant Staphylococcus aureus with linezolid. Infection 2007, 35:271-274.
13. LaPlante K.L., Woodmansee S. Activities of daptomycin and vancomycin alone and in combination with rifampin and gentamicin against biofilm-forming methicillin-resistant Staphylococcus aureus isolates in an experimental model of endocarditis. Antimicrob. Agents Chemother. 2009, 53:3880-3886.
14. Lee D.H., Palermo B., Chowdhury M. Successful treatment of methicillin-resistant staphylococcus aureus meningitis with daptomycin. Clin. Infect. Dis. 2008, 47:588-590.
15. Olson M.E., Slater S.R., Rupp M.E., Fey P.D. Rifampicin enhances activity of daptomycin and vancomycin against both a polysaccharide intercellular adhesin (PIA)-dependent and -independent Staphylococcus epidermidis biofilm. J. Antimicrob. Chemother. 2010, 65:2164-2171.
16. Pillai S.K., Moellering R.C., Eliopoulos G.M. Antimicrobial combinations. Antibiotics in Laboratory Medicine 2005, 345-441. Lippincott Williams & Wilkins, Philadelphia. V. Lorian (Ed.).
17. Steed M.E., Vidaillac C., Rybak M.J. Novel daptomycin combinations against daptomycin-nonsusceptible methicillin-resistant Staphylococcus aureus in an in vitro model of simulated endocardial vegetations. Antimicrob. Agents Chemother. 2010, 54:5187-5192.
18. Weiss E.C., Zielinska A., Beenken K.E., Spencer H.J., Daily S.J., Smeltzer M.S. Impact of sarA on daptomycin susceptibility of Staphylococcus aureus biofilms in vivo. Antimicrob. Agents Chemother. 2009, 53:4096-40102.